Abbott Korea launches obesity-free company campaign

Published: 2004-01-30 06:56:00

Updated: 2004-01-30 06:56:00

Abbott Korea, a pharmaceutical maker of Reductil (sibutramine hydrochloride monohydrate) intended for the management of obesity, said recently its ongoing obesity-free company campaign is gaining positive response from employees, which is the first attempt among the Korean corporations.

This c...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK